Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99.6M
-
Number of holders
-
262
-
Total 13F shares, excl. options
-
92M
-
Shares change
-
-1.83M
-
Total reported value, excl. options
-
$7.63B
-
Value change
-
-$147M
-
Put/Call ratio
-
0.85
-
Number of buys
-
135
-
Number of sells
-
-117
-
Price
-
$82.93
Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q1 2018
316 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q1 2018.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 262 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92M shares
of 99.6M outstanding shares and own 92.4% of the company stock.
Largest 10 shareholders include FMR LLC (13.4M shares), JANUS HENDERSON GROUP PLC (7.46M shares), VANGUARD GROUP INC (7.31M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.26M shares), BlackRock Inc. (4.91M shares), PERCEPTIVE ADVISORS LLC (4.76M shares), BB BIOTECH AG (3.4M shares), Invesco Ltd. (2.37M shares), WELLINGTON MANAGEMENT GROUP LLP (2.37M shares), and FRANKLIN RESOURCES INC (2.36M shares).
This table shows the top 262 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.